Recently Released Market Study: Prediction Sciences - Product Pipeline Analysis
Prediction Sciences (Prediction) is a medical device company, based in the US. The company develops and markets molecular diagnostics and assays for disease detection, prognosis, and treatment. Its pipeline includes GeneRxTM colorectal cancer profile, GeneRxTM lithium/bipolar test, and GeneRxTM for hypertension treatment. The company provides clarient insight Dx breast cancer profile to determine risk of recurrence in patients with operable breast cancer. Its RapidResponse c-Fn test is used to anticipate hemorrhagic transformation in stroke patients who are candidates for thrombolytic...
View full press release